STRIPPOLI, SABINO
 Distribuzione geografica
Continente #
NA - Nord America 569
EU - Europa 150
AS - Asia 56
OC - Oceania 1
Totale 776
Nazione #
US - Stati Uniti d'America 569
SE - Svezia 39
IT - Italia 32
CN - Cina 30
DE - Germania 27
SG - Singapore 16
GB - Regno Unito 13
IE - Irlanda 8
FR - Francia 7
RU - Federazione Russa 7
VN - Vietnam 5
FI - Finlandia 4
IN - India 4
NL - Olanda 4
BE - Belgio 2
UA - Ucraina 2
AT - Austria 1
AU - Australia 1
JP - Giappone 1
NO - Norvegia 1
PT - Portogallo 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 776
Città #
Fairfield 94
Chandler 71
Woodbridge 55
Ashburn 51
Seattle 39
Nyköping 37
Cambridge 35
Houston 30
Ann Arbor 21
Wilmington 20
New York 14
Beijing 13
Bari 12
Lawrence 12
Inglewood 11
Roxbury 11
Des Moines 8
Dublin 8
San Diego 7
Dearborn 6
Nanjing 6
Singapore 6
Dong Ket 5
Jacksonville 5
Princeton 4
Amsterdam 3
Bologna 3
Los Angeles 3
Mottola 3
Paris 3
Pune 3
Brussels 2
Munich 2
Terlizzi 2
Triggiano 2
Wuhan 2
Boardman 1
Bratislava 1
Brooklyn 1
Cerignola 1
Chiswick 1
Cluj-napoca 1
Edinburgh 1
Groningen 1
Guangzhou 1
Hebei 1
Helsinki 1
Hounslow 1
Jiaxing 1
Kunming 1
Lisbon 1
London 1
Marseille 1
Milan 1
Monmouth Junction 1
New Bedfont 1
Noicattaro 1
Oslo 1
Prescot 1
Prineville 1
Redwood City 1
Shenyang 1
Southwark 1
Sydney 1
Taranto 1
Tokyo 1
Vienna 1
Washington 1
Totale 641
Nome #
Ocular toxicity in metastatic melanoma patients treated with mitogen-activated protein kinase kinase inhibitors: A case series 137
Detrimental effects of melanocortin-1 receptor (MC1R) variants on the clinical outcomes of BRAF V600 metastatic melanoma patients treated with BRAF inhibitors 109
The Management of Oligoprogression in the Landscape of New Therapies for Metastatic Melanoma 96
Influence of melanocortin-1 receptor (MC1R) polymorphisms on clinical outcomes of patients with metastatic melanoma harboring the BRAF mutation and treated with BRAF inhibitors 93
The search for a melanoma-tailored chemotherapy in the new era of personalized therapy: a phase II study of chemo-modulating temozolomide followed by fotemustine and a cooperative study of GOIM (Gruppo Oncologico Italia Meridionale) 82
Negative influence of Melanocortin-1 receptor (MC1R) polymorphisms on clinical outcomes of metastatic melanoma (MM) patients (pts) harboring BRAF mutation and treated with BRAF inhibitors (BRAFi) 62
Anti-PD1 antibodies in patients aged ≥ 75 years with metastatic melanoma: A retrospective multicentre study 48
Case Report: Lymphocytosis Associated With Fatal Hepatitis in a Thymoma Patient Treated With Anti-PD1: New Insight Into the Immune-Related Storm 42
An Italian Retrospective Survey on Bone Metastasis in Melanoma: Impact of Immunotherapy and Radiotherapy on Survival 38
The β-adrenergic receptor antagonist propranolol offsets resistance mechanisms to chemotherapeutics in diverse sarcoma subtypes: a pilot study 35
The Genetic Germline Background of Single and Multiple Primary Melanomas 33
null 29
Oversecretion of Cytokines and Chemokines in Lupus Nephritis Is Regulated by Intraparenchymal Dendritic Cells A Review 15
BRAFV600E;K601Q metastatic melanoma patient-derived organoids and docking analysis to predict the response to targeted therapy 15
Melanoma Brain Metastases: A Retrospective Analysis of Prognostic Factors and Efficacy of Multimodal Therapies 9
Circulating extracellular vesicles are monitoring biomarkers of anti-PD1 response and enhancer of tumor progression and immunosuppression in metastatic melanoma 5
Totale 848
Categoria #
all - tutte 4.398
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.398


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020183 19 4 1 27 18 17 13 20 25 15 17 7
2020/2021192 12 13 10 12 28 36 18 10 7 22 15 9
2021/202295 4 0 3 1 4 10 1 2 15 7 20 28
2022/2023173 23 35 8 16 17 20 4 22 24 2 2 0
2023/202497 4 18 5 3 11 31 0 5 2 3 1 14
2024/202515 15 0 0 0 0 0 0 0 0 0 0 0
Totale 848